Veno-occlusive disease of the liver following bone marrow transplantation: A clinical-pathological study of autopsy cases

Artificial Organs

Volumn 20, Issue 10, 1996, Pages 1145-1150

  Watanabe, Kazushige ^a   Iwaki, Hiroyuki ^a   Satoh, Masaaki ^a   Ikeda, Tatsuru ^a   Ichimiya, Shingo ^a   Suzuki, Nobuhiro ^a   Kudoh, Tooru ^a   Oda, Takanori ^a   Matsuura, Akihiro ^a   Mori, Michio ^a   Kikuchi, Kokichi ^a  

^a SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bone marrow transplantation; Chemotherapy; Leukemia; Stem cell transplantation

Indexed keywords

BONE; CHEMOTHERAPY; CYTOLOGY; DISEASE CONTROL; PROTEINS; STEM CELLS;

ABDOMINAL PAIN; BONE MARROW TRANSPLANTATION; BUSULFAN; CLINICAL SYNDROMES; HEPATIC VEINS; IMMUNOHISTOCHEMICAL ANALYSIS; INTENSIVE THERAPY; LIVER FUNCTIONS; OCCLUSIVE DISEASE; STEM CELL TRANSPLANTATION;

DISEASES;

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LIVER VENOOCCLUSIVE DISEASE; MALE; PRIORITY JOURNAL;

EID: 10244240573     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb00652.x     Document Type: Conference Paper

References (13)

1. MacDonald GB, Sharma HM, Wolford JL, Spencer GD. Liver disease after bone marrow transplantation. Semin Liver Dis 1987;7:210-5.
2. Jeklliffe DB, Bras G, Mukherjee KL. Veno-occlusive disease of the liver and Indian childhood cirrhosis. Arch Dis Child 1957;32:369-74.
3. Otte JB, de Ville de Goyet J, Sokal TE. Size reduction of the donor liver is a safe way to alleviate the shortage of size matched organs in pediatric liver transplantation. Ann Surg 1990;211:117-22.
4. Friedman SL. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. New Engl J Med 1993;328: 1828-35.
5. Gresser AM. Perisinusoidal lipocytes and fibrogenesis. Gut 1994;26:1331-3.
6. Soiffer RJ, Dear K, Rabinowe SN, Anderson KC, Freedman AS, Murray C, Tarbell NJ, Mause P, Nadler LM, Ritz J. Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation. Transplantation 1991;52: 1014-9.
7. MacDonald GB, Sharma P, Mattews DE. Veno-occlusive disease of the liver after bone marrow transplantation: Diagnosis, incidence and predisposing factors. Hepatology 1984;4:116-20.
8. Jones RJ, Lee KS, Beschorner WE. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778-84.
9. Dulley FL, Kanfer EJ, Appelbaum FR. Veno-occlusive of the liver after chemotherapy and autologous bone marrow transplantation. Transplantation 1987;43:870-6.
10. 14C-busulfan in isolated perfused rat liver. Eur J Drug Met Pharmacokinet 1987;12:71-6.
11. Vassal G, Challine C, Koscielny S, Hartman O, Deroussent A, Boland I, Valtau-Couanet D, Lemerle J, Levi F, Gouyette A. Chronopharmacology of high-dose busulfan in children. Cancer Res 1993;53:1537-54.
12. Lazarus HM, Gottfried MR, Herzig RH, Phillips GL, Weiner RS, Sarna GP, Fay J, Wolff SN, Sudilovsky O, Gale RP, Herzig G. Veno-occlusive disease of the liver after high dose mitomycin therapy and autologous bone marrow transplantation. Cancer 1982;49:1789-95.
13. van de Rijn M, Rous RV. CD34: A review. Appl Immunohistochem 1994;2(2):71-80.